Drug Shortage Report for BIO-LEVETIRACETAM
Report ID | 131506 |
Drug Identification Number | 02450356 |
Brand name | BIO-LEVETIRACETAM |
Common or Proper name | LEVETIRACETAM |
Company Name | BIOMED PHARMA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LEVETIRACETAM |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 120 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-12-31 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-01-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-01-13 | English | Compare |
v2 | 2021-01-13 | French | Compare |
Showing 1 to 2 of 2